全文获取类型
收费全文 | 10028篇 |
免费 | 244篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 95篇 |
儿科学 | 401篇 |
妇产科学 | 2088篇 |
基础医学 | 1094篇 |
口腔科学 | 457篇 |
临床医学 | 1026篇 |
内科学 | 1188篇 |
皮肤病学 | 164篇 |
神经病学 | 565篇 |
特种医学 | 492篇 |
外科学 | 1041篇 |
综合类 | 89篇 |
一般理论 | 1篇 |
预防医学 | 817篇 |
眼科学 | 216篇 |
药学 | 307篇 |
中国医学 | 48篇 |
肿瘤学 | 211篇 |
出版年
2018年 | 80篇 |
2017年 | 97篇 |
2016年 | 57篇 |
2015年 | 76篇 |
2014年 | 107篇 |
2013年 | 340篇 |
2012年 | 139篇 |
2011年 | 213篇 |
2010年 | 182篇 |
2009年 | 334篇 |
2008年 | 314篇 |
2007年 | 238篇 |
2006年 | 276篇 |
2005年 | 274篇 |
2004年 | 237篇 |
2003年 | 229篇 |
2002年 | 208篇 |
2001年 | 115篇 |
2000年 | 113篇 |
1999年 | 325篇 |
1998年 | 305篇 |
1997年 | 354篇 |
1996年 | 368篇 |
1995年 | 319篇 |
1994年 | 284篇 |
1993年 | 211篇 |
1992年 | 223篇 |
1991年 | 238篇 |
1990年 | 180篇 |
1989年 | 166篇 |
1988年 | 159篇 |
1987年 | 135篇 |
1986年 | 173篇 |
1985年 | 146篇 |
1984年 | 123篇 |
1983年 | 155篇 |
1982年 | 107篇 |
1981年 | 101篇 |
1980年 | 122篇 |
1979年 | 106篇 |
1978年 | 75篇 |
1977年 | 106篇 |
1976年 | 110篇 |
1975年 | 106篇 |
1974年 | 78篇 |
1973年 | 78篇 |
1972年 | 51篇 |
1971年 | 50篇 |
1970年 | 54篇 |
1922年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Daniel J. Wallace MD Associate Clinical Professor of Medicine 《Seminars in arthritis and rheumatism》1989,18(4):282-296
Atabrine has been available for nearly 60 years. It has a variety of actions and has been administered to millions of individuals. Its antirheumatic properties have been well documented but have not been exploited optimally for a variety of reasons. The drug is generally quite safe and could be used in low doses in lupus and rheumatoid arthritis patients as a steroid-sparing agent or synergistically with hydroxychloroquine. Its bothersome side effects should not deter the clinician from using it, because they are easy to deal with or prevent (Table 5). Future studies should attempt to better characterize the immunosuppressive actions of this powerful drug, particularly in the treatment of lupus erythematosus and rheumatoid arthritis. Studies of the role of combination or single-agent antimalarial therapy in combination with other "remittive" drugs could be of great potential benefit. 相似文献
92.
The series comprises 70 women with climacteric symptoms; 14 of them were oophorectomized. The first group of patients received 4 mg of oestriol succinate per day or a placebo in a double-blind experiment. In the second part of the study oophorectomized women were given 8 mg of oestriol succinate per day or 16 mg/day divided into two doses. Serum total cholesterol, HDL-cholesterol and serum triglycerides were estimated before drug treatment and after drug administration for three and six months. Administration of 4–16 mg/day of oestriol succinate was without effect on serum total cholesterol. A significant increase of 25–30% in HDL-cholesterol was observed following administration of oestriol succinate (8 mg or 16 mg divided into two doses) with a rising tendency in total triglyceride value. 相似文献
93.
94.
Akbar F Heinonen S Pirskanen M Uimari P Tuomainen TP Salonen JT 《Molecular human reproduction》2005,11(1):73-77
Association between pre-eclampsia (PEE1) and the dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 genes, which play a role in the regulation of nitric oxide synthesis and release, was studied. In a case-control study design single nucleotide polymorphisms (SNPs) were determined at eight sites in the DDAH1 gene and at one site (Pro231Pro) in the DDAH2 gene from 132 women with pre-eclampsia and 112 healthy controls. Three SNPs in the DDAH1 gene were associated with pre-eclampsia, showing complete linkage disequilibrium with each other, but none of the associations in the allele or genotype data reached statistical significance in either of the genes after the correction for multiple testing. Haplotype frequencies were estimated using a population based on a maximum likelihood method (EM algorithm). Four common DDAH1 haplotypes were present and a significant association of haplotypes H2 and H3 with pre-eclampsia (P=0.03) was found. The risk of pre-eclampsia was greatest in individuals (odds ratio: 3.93; 95% confidence interval: 1.54-9.99) who had two copies of the high-risk haplotypes (H2 or H3). The observed haplotypic association provides the first evidence of the importance of DDAH1 polymorphisms in pre-eclampsia susceptibility. 相似文献
95.
Pekka Oja Raija M. T. Laukkanen T. Katriina Kukkonen-Harjula Ilkka M. Vuori Matti E. Pasanen Seppo P. T. Niittymäki Tiina Solakivi 《European journal of applied physiology》1991,62(6):400-404
Summary Two experiments were carried out to compare the cardiorespiratory and metabolic effects of cross-country skiing and running training during two successive winters. Forty-year-old men were randomly assigned into skiing (n = 15 in study 1,n = 16 in study 2), running (n = 16 in study 1 andn = 16 in study 2) and control (n = 17 in study 1 andn = 16 in study 2) groups. Three subjects dropped out of the programme. The training lasted 9–10 weeks with 40-min exercise sessions three times each week. The training intensity was controlled at 75%–85% of the maximal oxygen consumption (VO2max) using portable heart rate metres and the mean heart rate was 156–157 beats·min–1 in the training groups. In the pooled data of the two studies the mean increase in theVO2max (in ml·min–1·kg–1) on a cycle ergometer was 17% for the skiing group, 13% for the running group and 2% for the control group. The increase inVO2max was highly significant in the combined exercise group compared to the control group but did not differ significantly between the skiing and running groups. The fasting serum concentrations of lipoproteins and insulin did not change significantly in any of the groups. These results suggested that training by cross-country skiing and running of the same duration and intensity at each session for 9–10 weeks improved equally the cardiorespiratory fitness of untrained middle-aged men. 相似文献
96.
Acquired Resistance of Escherichia coli to Complement Lysis by Binding of Glycophosphoinositol-Anchored Protectin (CD59)
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Riina Rautemaa Gary A. Jarvis Pertti Marnila Seppo Meri 《Infection and immunity》1998,66(5):1928-1933
Protectin (CD59) is a glycophosphoinsitol (GPI)-anchored defender of human cells against lysis by the membrane attack complex of complement. In this study, we examined whether protectin released from human cell membranes can incorporate into the surface of gram-negative bacteria. Analysis by using radiolabeled protectin, immunofluorescence, flow cytometry, and whole-cell enzyme-linked immunosorbent assay demonstrated that protectin bound to nonencapsulated Escherichia coli EH237 (Re) and EH234 (Ra) in a calcium-dependent manner. The incorporation required the GPI-phospholipid moiety since no binding of a phospholipid-free soluble form of protectin was observed. Mg2+ did not enhance the binding, and a polysialic acid capsule prevented it (strain IH3080 [O18:K1:H8]). Bound protectin inhibited the C5b-9 neoantigen expression on complement-treated bacteria. Protection against complement lysis was observed in both a colony counting assay and a bioluminescence assay, where viable EH234 bacteria expressing the luciferase gene emitted green light in the presence of the luciferine substrate. In general, two- to four-times-higher serum concentrations were needed to obtain 50% lysis of protectin-coated versus noncoated bacteria. The results indicate that protectin can incorporate in a functionally active form into the cell membranes of the two nonencapsulated deep rough E. coli strains studied. 相似文献
97.
Professor K. M. Patil M. S. Srinath 《Medical & biological engineering & computing》1990,28(5):416-422
A new image-processing system, using a video digitiser with an IBM-compatible PC/AT, is developed for acquisition and processing
of low-contrast, lowintensity barographic images of both feet for assessment of pressure distribution during standing and
walking. Data displays, in the form of centres of pressures, isopressures contours, perspective views of pressures, grey scale
image and walking pressure patterns, combined image of walking pressures, paths of centres of pressures and pressure variations
with time, are developed. These have provided very useful and early information regarding the internal structural changes
in the bones of the foot and sites at risk of ulcer development in leprosy subjects and enable suitable corrective orthopaedic
procedures to be adopted.
unitl the end of November 1990, and will then return to the Indian Institute of Technology. 相似文献
98.
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration 总被引:11,自引:0,他引:11
下载免费PDF全文
![点击此处可从《The American journal of pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rissanen TT Vajanto I Hiltunen MO Rutanen J Kettunen MI Niemi M Leppänen P Turunen MP Markkanen JE Arve K Alhava E Kauppinen RA Ylä-Herttuala S 《The American journal of pathology》2002,160(4):1393-1403
Vascular endothelial growth factor (VEGF) is a hypoxia-inducible endothelial cell mitogen and survival factor. Its receptor VEGFR-2 (KDR/Flk-1) mediates these effects. We studied the expression of VEGF and VEGFR-2 in ischemic human and rabbit skeletal muscle by immunohistochemistry and in situ hybridization. Human samples were obtained from eight lower limb amputations because of acute or chronic critical ischemia. In chronically ischemic human skeletal muscle VEGF and VEGFR-2 expression was restricted to atrophic and regenerating skeletal myocytes, whereas in acutely ischemic limbs VEGF and VEGFR-2 were expressed diffusely in the affected muscle. Hypoxia-inducible factor-1alpha was associated with VEGF and VEGFR-2 expression both in acute and chronic ischemia but not in regeneration. Hindlimb ischemia was induced in 20 New Zealand White rabbits by excising the femoral artery. Magnetic resonance imaging and histological sections revealed extensive ischemic damage in the thigh and leg muscles of ischemic rabbit hindlimbs with VEGF expression similar to acute human lower limb ischemia. After 1 and 3 weeks of ischemia VEGF expression was restricted to regenerating myotubes and by 6 weeks regeneration and expression of VEGF was diminished. VEGFR-2 expression was co-localized with VEGF expression in regenerating myotubes. Macrophages and an increased number of capillaries were associated with areas of ischemic muscle expressing VEGF and VEGFR-2. In conclusion, two patterns of VEGF and VEGFR-2 expression in human and rabbit ischemic skeletal muscle are demonstrated. In acute skeletal muscle ischemia VEGF and VEGFR-2 are expressed diffusely in the affected muscle. In chronic skeletal muscle ischemia and in skeletal muscle recovering from ischemia VEGF and VEGFR-2 expression are restricted to atrophic and regenerating muscle cells suggesting the operation of an autocrine pathway that may promote survival and regeneration of myocytes. 相似文献
99.
Lejeune F Liénard D Eggermont A 《BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy》1998,9(3):211-218
Recombinant tumour necrosis factor-alpha (rTNFalpha) possesses the unique property of activating and selectively destroying the tumour-associated microvasculature. Systemic application of rTNFalpha has shown that the maximum tolerated dose (MTD) is 10 times lower than the efficient dose in animals. The main toxicity corresponds to the systemic inflammatory response syndrome (SIRS), with a decrease of vascular resistance and hypotension. We found that it is possible to administer rTNFalpha at 10 times the MTD in an isolated limb perfusion system, using a heart-lung machine, for advanced melanoma and sarcoma of the limbs. Our results, using the combination of high dose rTNFalpha, interferon-gamma and melphalan (TIM), produced an overall objective response rate of 100% in 2 successive studies on melanoma, with 90% and 78% complete response, respectively. In sarcoma, there was an overall response rate of 64%, with 36% complete response. Angiographic and immunohistological studies demonstrated selective and early damage of the tumour-associated microvasculature, preceded by upregulation of adhesion molecules and intratumoural leak of von Willebrand factor. Tumour invasion by platelets and, in some cases, by polymorphonuclear cells, appeared within hours after the application of rTNFalpha, long before the lysis of the tumour. Systemic changes after rTNFalpha treatment included the production of soluble TNFalpha receptors and of interleukin-6. A typical acute phase reaction was observed within 3 days, with increase of C-reactive protein parallelled by an increase of tenascin-C. A selective effect on intratumoural endothelial cells seems to be involved in the mechanism of the impressive antitumour effect of rTNFalpha, but the role of acute phase protein production is not fully understood. In selected cases of melanoma, specific cytotoxic T lymphocytes were increased after perfusion. 相似文献
100.
Peiwen Pan Mari Leppilampi Silvia Pastorekova Jaromir Pastorek Abdul Waheed William S. Sly Seppo Parkkila 《The Journal of physiology》2006,571(2):319-327
Using real-time PCR and immunohistochemistry, we have examined the expression of carbonic anhydrase isozymes (CA) I, II, III, IV, IX, XII, XIII and XIV in the brain, kidney, stomach and colon of the wild-type, CA II-deficient ( Car2−/− ), and CA IX deficient ( Car9−/− ) mice. The expression of Car4, Car12, Car13 and Car14 mRNAs did not show any significant deviations between the three groups of mice, whereas both groups of CA deficient mice showed decreased expression levels of Car1 in the colon and Car3 in the kidney. The Car2 mRNA level was greatly reduced but not completely abolished in all four tissues from the Car2−/− mice in which no CA II protein was expressed. Sequencing the Car2 cDNA isolated from C57BL6 Car2−/− mice revealed two nucleotide differences from the wild-type C57BL6 mice. One is a silent polymorphism found in Car2 mRNA from wild-type DBA mice, which is the strain that provided the original mutagenized chromosome. The second change is a mutation that causes prematurely terminated translation at codon 155 (Gln155X). Car9 mRNA and CA IX protein expression levels were up-regulated about 2.5- and 3.6-fold, respectively, in the stomach of the Car2−/− mice. These results suggest that the loss of function of cytosolic CA II in the stomach of Car2−/− mice leads to up-regulation of an extracellular CA, namely CA IX, which is expressed on the cell surface of the gastric epithelium. 相似文献